Travel Medicine Update

Icahn School of Medicine at Mount Sinai

D. Caplivski

Nirsevimab for RSV: A Breakthrough Product for Babies

MicrobeTV

P. Offit, V. Racaniello

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

COVID 2024 Surge: The Most Accessible Defense

MedCram

R. Seheult

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Underst…

Jaime Seltzer

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

What's New with COVID in 2024?

Michigan Medicine

L. Washer

Long COVID and 'Long Lyme': More in Common Than Meets the Eye

International Lyme and Associated Diseases Society (ILADS)

J. S. Lambert

The Durability of the Antibody Response Following Monkeypox Vaccinat…

MicrobeTV

D. Griffin, V. Racaniello

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello

Newly Licensed Respiratory Syncytial Virus Vaccines for Adults: What…

MicrobeTV

P. Offit, V. Racaniello

Monkeypox Declared a Public Health Emergency of International Concer…

MicrobeTV

D. Griffin, V. Racaniello

Long COVID and ME/CFS: Are They the Same Condition?

Charles Shepherd

Preventing Complications with Vaccines in Persons with Diabetes (PWD)

Allison Presnell

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

Mpox Circulation and New Vaccine Approval, Largest Outbreak of Whoop…

MicrobeTV

D. Griffin, V. Racaniello

Vaccination vs. Antiviral Therapy Against Mpox, Authorization and Ap…

MicrobeTV

D. Griffin, V. Racaniello

September 2024 Public Health Infectious Disease Updates

California Medical Association

E. Pan

What Happened to Monkeypox and Why Have Cases Declined?

MedCram

R. Seheult